王敏, 王骏, 邵明远, 王敏, 王以光. 链霉菌产生的新型纤溶酶的纤溶性质和溶栓作用J. 药学学报, 1998, 33(7): 481-485.
引用本文: 王敏, 王骏, 邵明远, 王敏, 王以光. 链霉菌产生的新型纤溶酶的纤溶性质和溶栓作用J. 药学学报, 1998, 33(7): 481-485.
Wang Min, Wang Jun, Shao Mingyuan, Wang Min , Wang Yiguang, . FIBRINOLYTIC PROPERTIES AND THROMBOLYTIC EFFECT OF A NOVEL FIBRINOLYTIC ENZYME FROM STREPTOMYCES SP. Y405J. Acta Pharmaceutica Sinica, 1998, 33(7): 481-485.
Citation: Wang Min, Wang Jun, Shao Mingyuan, Wang Min , Wang Yiguang, . FIBRINOLYTIC PROPERTIES AND THROMBOLYTIC EFFECT OF A NOVEL FIBRINOLYTIC ENZYME FROM STREPTOMYCES SP. Y405J. Acta Pharmaceutica Sinica, 1998, 33(7): 481-485.

链霉菌产生的新型纤溶酶的纤溶性质和溶栓作用

FIBRINOLYTIC PROPERTIES AND THROMBOLYTIC EFFECT OF A NOVEL FIBRINOLYTIC ENZYME FROM STREPTOMYCES SP. Y405

  • 摘要: 目的旨在进一步确证纤溶活性的蛋白酶SW-1的溶栓作用和性质。用体外加热平板法、试管凝块法和在体内对大鼠静脉血栓溶解及对纤溶因子的作用等实验,发现SW-1在体外可直接降解纤维蛋白,而无激活纤溶酶原的作用。在体内,SW-1对大鼠静脉血栓有显著的溶解效果,与同剂量尿激酶的溶栓作用相当。给药(iv)30min后,SW-1引起大鼠血浆中纤溶酶、纤溶酶原水平提高,纤维蛋白原水平下降,而对组织型纤溶酶原激活剂(t-PA)、α2-纤溶酶抑制剂无显著影响。提示SW-1是一种具有纤溶活性的蛋白酶,而不是纤溶原激活剂。

     

    Abstract: A novel protease (designated as SW-1) purified from the fermentation broth of Streptomyces sp. strain Y405 showed fibrinolytic activity. In vitro, on plasminogenfree fibrin plate which had been heated at 85℃ for 30 minutes to eliminate plasminogen, SW-1 showed the same fibrinolytic activity as the mixture of SW-1 and plasminogen. Without adding plasminogen into the fibrin clot tube SW-1 showed the same effect as with plasminogen(P>0.05). The results might indicate that SW-1 is a fibrinolytic enzyme which degrades fibrin directly, but not a plasminogen activator which degrades fibrin by activating plasminogen. SW-1 was found also to degrade fibrinogen. In vivo, the thrombolytic effect of SW-1(4000 u·kg-1) on venous thrombus in rat was most remarkable versus that of control(P<0.001), but was not divergent versus that of urokinase at the same dose(P>0.05). SW-1 was shown to enhance plasminogen and plasmin activity but did not show significant effect on endogenous t-PA or α2-PI. SW-1 also caused decrease of fibrinogen level in plasma, indicating that it degrades the fibrin in thrombus and at the same time degrades the circulating fibrinogen to certain extent. The changes of these biochemical data demonstrated the thrombolytic properties of SW-1 in vivo.

     

/

返回文章
返回